Drugs / Tetrahydrobiopterin (BH4)
last change Jul 2018 re-read 3 minutes ago

Tetrahydrobiopterin (BH4)

Developed for
chronic obstructive pulmonary disease
Investigated by
Augusta University

Trials 1

201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02774226 Sep 2015 → Jul 2018 chronic obstructive pulmonary disease Augusta University Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Tetrahydrobiopterin (BH4) ClinicalTrials.gov intervention name — accepted as the source's own label NCT02774226 ↗